|
1
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nav Rev Genet. 5:522–531.
2004.PubMed/NCBI View
Article : Google Scholar
|
|
2
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism and function. Cell. 116:281–297.
2004.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Liu X, Li M, Peng Y, Hu X, Xu J, Zhu S, Yu
Z and Han S: miR-30c regulates proliferation, apoptosis and
differentiation via the Shh signaling pathway in P19 cells. Exp Mol
Med. 48(e248)2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Vidal AF, Cruz AM, Magalhães L, Pereira
AL, Anaissi AK, Alves NC, Albuquerque PJ, Burbano RM, Demachki S
and Ribeiro-dos-Santos Â: hsa-miR-29c and hsa-miR-135b differential
expression as potential biomarker of gastric carcinogenesis. World
J Gastroenterol. 22:2060–2070. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Bansal N, Dhaliwal R and Weinstock RS:
Management of diabetics in the elderly. Med Clin North Am.
99:351–377. 2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Nam S, Chesla C, Stotts NA, Kroon L and
Janson SL: Barriers to diabetes management: Patient and provider
factors. Diabetes Res Clin Pract. 93:1–9. 2011.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Abboud HE: Mesangial cell biology. Exp
Cell Res. 318:979–985. 2012.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Danesh FR, Sadeghi MM, Amro N, Philips C,
Zeng L, Lin S, Sahai A and Kanwar YS: 3-Hydroxy-3-methylglutaryl
CoA reductase inhibitors prevent high glucose-induced proliferation
of mesangial cells via modulation of Rho GTPase/p21 signaling
pathway: Implications for diabetic nephropathy. Proc Natl Acad Sci
USA. 99:8301–8305. 2002.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Liu ZM, Zheng HY, Chen LH, Li YL, Wang Q,
Liao CF and Li XW: Low expression of miR-203 promoted diabetic
nephropathy via increasing TLR4. Eur Rev Med Pharmacol Sci.
22:5627–5634. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zhao D, Jia J and Shao H: iR-30e targets
GLIPR-2 to modulate diabetic nephropathy: In vitro and in vivo
experiments. J Mol Endocrinol. 59:181–190. 2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Wang J, Duan L, Gao Y, Zhou S, Liu Y, Wei
S, An S, Liu J, Tian L and Wang S: Angiotensin II receptor blocker
valsartan ameliorates cardiac fibrosis partly by inhibiting miR-21
expression in diabetic nephropathy mice. Mol Med Endorcrinol.
472:149–158. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
He YQ, Ding YL, Liang BY, Lin JJ, Kim TY,
Yu HB, Hang HW and Wang K: A systematic study of dysregulated
microRNA in type 2 diabetes mellitus. Int J Mol Sci. 18:
pii(456)2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Assmann TS, Recamonde-Mendoza M, De Souza
BM and Crispim D: MicroRNA expression profiles and type 1 diabetes
mellitus: Systematic review and bioinformatic analysis. Endocr
Connect. 6:773–790. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Tetreault MP, Yang Y and Katz JP:
Krüppel-like factors in cancer. Nat Rev Cancer. 13:701–713.
2013.PubMed/NCBI View
Article : Google Scholar
|
|
15
|
Huang X, Li X and Guo B: KLF6 induces
apoptosis in prostate cancer cells through up-regulation of ATF3. J
Biol Chem. 283:29795–29801. 2008.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wahab AH, Kassem AM, Matter S, EI Deen AF,
Helmy AS, Ismaeil MM and Zakaria MS: Role of KLF6 tumor suppressor
gene mutations in the development of colorectal carcinoma in an
Egyptian population. Hepatogastroenterology. 57:1405–1410.
2010.PubMed/NCBI
|
|
17
|
Rane MJ, Zhao Y and Cai L: Krüppel-like
factors (KLFs) in renal physiology and disease. EBioMedicine.
40:743–750. 2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Xu S, Lv YY, Zhao J, Wang JP, Zhao X and
Wang S: Inhibitory effects of Shenkang injection and its main
component emodin on the proliferation of high glucose-induced renal
mesangial cells through cell cycle regulation and induction of
apoptosis. Mol Med Rep. 14:3381–3388. 2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Li Y, Kuscu C, Banach A, Zhang Q,
Pulkoski-Gross A, Kim D, Liu J, Roth E, Li E, Shroyer KR, et al:
MiR-181a-5p inhibits cancer cell migration and angiogenesis via
downregulation of matrix metalloproteinase-14. Cancer Res.
75:2674–2685. 2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Taylor MA, Sossey-Alaoui K, Thompson CL,
Danielpour D and Schiemann WP: TGF-β upregulates miR-181a
expression to promote breast cancer metastasis. J Clin Invest.
123:150–163. 2013.PubMed/NCBI View
Article : Google Scholar
|
|
22
|
Wei Y, Tao X, Xu H, Chen Y, Zhu L, Tang G,
Li M, Jiang A, Shuai S, Ma J, et al: Role of miR-181a-5p and
endoplasmic reticulum stress in the regulation of myogenic
differentiation. Gene. 592:60–70. 2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Li S, Yang J, Xia Y, Fan Q and Yang KP:
Long noncoding RNA NEAT1 promotes proliferation and invasion via
targeting miR-181a-5p in non-small cell lung cancer. Oncol Res.
26:289–296. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Yu C, Sun J, Leng X and Yang J: Long
noncoding RNA SNHG6 functions as a competing endogenous RNA by
sponging miR-181a-5p to regulate E2F5 expression in colorectal
cancer. Cancer Manag Res. 11:611–624. 2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Mi Y, Zhang D, Jiang W, Weng J, Zhou C,
Huang K, Tang H, Yu Y, Liu X, Cui W, et al: miR-181a-5p promotes
the progression of gastric cancer via RASSF6-mediated MAPK
signaling activation. Cancer Lett. 389:11–22. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zhang L, Pang S, Deng B, Qian L, Chen J,
Zou J, Zheng J, Yang L, Zhang C, Chen X, et al: High glucose
induces renal mesangial cell proliferation and fibronectin
expression through JNK/NF-κB/NADPH oxidase/ROS pathway, which is
inhibited by resveratrol. Int J Biochem Cell Biol. 44:629–638.
2012.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Sodhi CP, Phadke SA, Batlle D and Sahai A:
Hypoxia and high glucose cause exaggerated mesangial cell growth
and collagen synthesis: Role of osteopontin. Am J Physiol Renal
Physiol. 280:F667–F674. 2001.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Suzaki Y, Yoshizumi M, Kagami S, Nishiyama
A, Ozawa Y, Kyaw M, Izawa Y, Kanematsu Y, Tsuchiya K and Tamaki T:
BMK1 is activated in glomeruli of diabetic rats and in mesangial
cells by high glucose conditions. Kidney Int. 65:1749–1760.
2004.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Singh L, Pushker N, Saini N, Sen S, Sharma
A, Bakhshi S, Chawla B and Kashyap S: Expression of pro-apoptotic
Bax and anti-apoptotic Bcl-2 proteins in human retinoblastoma. Clin
Exp Ophthalmol. 43:259–267. 2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zhu Y, Tchkonia T, Fuhrmann-Stroissnigg H,
Dai HM, Ling YY, Stout MB, Pirtskhalava T, Giorgadze N, Johnson KO,
Giles CB, et al: Identification of a novel senolytic agent,
navitoclax, targeting the Bcl-2 family of anti-apoptotic factors.
Aging Cell. 15:428–435. 2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Ghibelli L and Diederich M: Multistep and
multitask Bax activation. Mitochondrion. 10:604–613.
2010.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Caruso Bavisotto C, Nikolic D, Marino
Gammazza A, Barone R, Lo Cascio F, Mocciaro E, Zummo G, Conway de
Macario E, Macario AJ, Cappello F, et al: The dissociation of the
Hsp60/pro-Caspase-3 complex by bis (pyridyl) oxadiazole copper
complex (CubipyOXA) leads to cell death in NCI-H292 cancer cells. J
Inorg Biochem. 170:8–16. 2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Qi W, Holian J, Tan CY, Kelly DJ, Chen XM
and Pollock CA: The roles of Kruppel-like factor 6 and peroxisome
proliferator-activated receptor-γ in the regulation of macrophage
inflammatory protein-3α at early onset of diabetics. Int J Biochem
Cell Biol. 43:383–392. 2011.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Ghahhari NM and Babashah S: Interplay
between microRNAs and Wnt/β-catenin signaling pathway regulates
epithelial-mesenchymal transition in cancer. Eur J Cancer.
51:1638–1649. 2015.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Mao J, Fan S, Ma W, Fan P, Wang B, Zhang
J, Wang H, Tang B, Zhang Q, Yu X, et al: Roles of Wnt/β-catenin
signaling in the gastric cancer stem cells proliferation and
salinomycin treatment. Cell Death Des. 5(e1039)2014.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Gao L, Chen B, Li J, Yang F, Cen X, Liao Z
and Long X: Wnt/β-catenin signaling pathway inhibits the
proliferation and apoptosis of U87 glioma cells via different
mechanisms. PLoS One. 12(e0181346)2017.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Lan XQ, Wen HX, Aslam R, Marashi Shoshtari
SS, Mishara A, Kumar V, Wang HC, Wu GS, Luo HR, Malhotra A and
Singhal PC: Nicotine enhances mesangial cell proliferation and
fibronectin production in high glucose milieu via activation of
Wnt/β-catenin pathway. Bioscience Rep. 38:
pii(BSR20180100)2018.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Xu P, Guan MP, Bi JG, Wang D, Zheng ZJ and
Xue YM: High glucose down-regulates microRNA-181a-5p to increase
pro-fibrotic gene expression by targeting early growth response
factor 1 in HK-2 cells. Cell Signal. 31:96–104. 2017.PubMed/NCBI View Article : Google Scholar
|
